1. Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations [WWW Document], n.d. URL https://www.accessdata.fda.gov/scripts/cder/ob/results_product.cfm?Appl_Type=N&Appl_No=203324#32580 (accessed 4.1.22).
2. Standard versus accelerated riboflavin–ultraviolet corneal collagen crosslinking: resistance against enzymatic digestion;Aldahlawi;J. Cataract Refract. Surg.,2015
3. Enzymatic resistance of corneas crosslinked using riboflavin in conjunction with low energy, high energy, and pulsed UVA irradiation modes;Aldahlawi;Invest. Ophthalmol. vis. Sci.,2016
4. Alió, J.L. (Ed.), 2017. Keratoconus: recent advances in diagnosis and treatment, 1st ed. Springer International Publishing.
5. Penetrating keratoplasty for keratoconus : visual and graft survival outcomes;Al-Mohaimeed;Int. J. Health Sci. (qassim),2013